225
Views
4
CrossRef citations to date
0
Altmetric
Drug Evaluation

Allogeneic mesenchymal precursor cells (MPCs): an innovative approach to treating advanced heart failure

, , , &
Pages 1163-1169 | Received 13 Apr 2016, Accepted 23 Jun 2016, Published online: 08 Jul 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Saeed Abbasalizadeh, Mohammad Pakzad, Joaquim M.S. Cabral & Hossein Baharvand. (2017) Allogeneic cell therapy manufacturing: process development technologies and facility design options. Expert Opinion on Biological Therapy 17:10, pages 1201-1219.
Read now

Articles from other publishers (3)

Roberto Bolli, Joshua M. Hare, Timothy D. Henry, Carrie G. Lenneman, Keith L. March, Kathy Miller, Carl J. Pepine, Emerson C. Perin, Jay H. Traverse, James T. Willerson, Phillip C. Yang, Adrian P. Gee, João A. Lima, Lem Moyé, Rachel W. Vojvodic, Shelly L. Sayre, Judy Bettencourt, Michelle Cohen, Ray F. Ebert & Robert D. Simari. (2018) Rationale and Design of the SENECA (StEm cell iNjECtion in cAncer survivors) Trial. American Heart Journal 201, pages 54-62.
Crossref
Khawaja H Haider. (2018) Bone marrow cell therapy and cardiac reparability: better cell characterization will enhance clinical success. Regenerative Medicine 13:4, pages 457-475.
Crossref
Jozef BartunekAndre TerzicAtta BehfarWilliam Wijns. (2018) Clinical Experience With Regenerative Therapy in Heart Failure. Circulation Research 122:10, pages 1344-1346.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.